Branded Drugs-Pharmaceuticals
Solicitation number E60PH-19BRND/A
Publication date
Closing date and time 2019/05/31 14:00 EDT
Description
Trade Agreement: Canadian Free Trade Agreement (CFTA)
Tendering Procedures: Generally only one firm has been invited to bid
Non-Competitive Procurement Strategy: Exclusive Rights
Comprehensive Land Claim Agreement: No
Vendor Name and Address:
VARIOUS PHARMACEUTICALS SUPPLIERS
VARIOUS
VARIOUS Ontario
Canada
A1A1A1
Nature of Requirements:
1. Definition of the requirement
PWGSC proposes to establish contract pricing with manufacturers of patent protected pharmaceuticals on behalf of the Federal/Provincial/Territorial (F/P/T) Group Purchasing Program for Drugs and Vaccines on an as-and-when requested basis.
2. Criteria for assessment of the Statement of Capabilities (Minimum Essential Requirements)
Any interested supplier must demonstrate by way of a statement of capabilities that its pharmaceutical product meets the following requirements:
a) Must have a valid DIN number;
b) Must have the same active pharmaceutical ingredient (API) and strength as indicated in the list below.
c) Must be able to deliver on a national scale.
3. Applicability of the trade agreement(s) to the procurement
This procurement is subject to the Canadian Free Trade Agreement (CFTA)
4. Justification for the Pre-Identified Supplier
This requirement is being negotiated with the following suppliers as they are the only known suppliers capable of providing the drugs listed at the bottom of this document. The suppliers are:
AA Pharma, AbbVie, Amgen, ASM Canada, Astra Zeneca, Bausch Health Canada Inc., Bayer, BGP Pharma, Biogen Idec Canada, Boehringer Ingelheim, Bristol-Myers Squibb, Church & Dwight, Eli Lilly, Galderma Canada, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen, Johnson & Johnson, Leo Pharma, Lundbeck, Mallinckrodt Canada, Merck, Novartis, Novo Nordisk, Omega Laboratories, Otsuka Canada Pharma, Pfizer Canada, Pharmascience, Purdue Pharma, Sanofi-Aventis, Shire Canada, Smith & Nephew, Sterimax, Sunovion Pharma, Takeda, Taro Pharmaceuticals, Teligent, Teva, Valeant, and Viiv Healthcare.
5. Government Contracts Regulations Exception(s)
The following exception(s) to the Government Contracts Regulations is invoked for this procurement under subsection 6(d) as only one supplier is capable of performing the work.
6. Period of the proposed contract or delivery date
From July 1, 2019 to June 30, 2020, with an option to extend the contract period for two additional one-year periods from July 1, 2020 to June 30, 2021 and July 1, 2021 to June 30, 2022.
7. Closing date for a submission of a statement of capabilities
The closing date and time for accepting statements of capabilities is May 31, 2019 at 2:00 p.m.
8. Inquiries and statements of capabilities are to be directed to:
Julia Summers
Telephone: (613) 859-0832
E-mail: julia.summers@tpsgc-pwgsc.gc.ca
LIST OF ITEMS
AVENTYL CAPS 10MG 100
AVENTYL CAPS 25MG 100
PEN VK TB 300MG 100
LUPRON DEPOT INJ KIT 11.25MG
LUPRON DEPOT INJ KIT 22.5MG1
LUPRON DEPOT INJ KIT 3.75MG
LUPRON DEPOT INJ KIT 30MG 1
LUPRON DEPOT INJ KIT 7.5MG 1
HUMIRA PN 40MG/0.8ML 2X0.8ML
KALETRA TB 200-50MG 120
NORVIR TB 100MG 30
ARANESP SYR 500MCG 1ML
ARANESP SYR 40MCG 4X0.4ML
ARANESP SYR 60MCG 4X0.3ML
ARANESP SYR 80MCG 4X0.4ML
ENBREL 50MG/ML SURECLICK 4
NEUPOGEN VL 300MCG 10X1ML
PULMICORT NEB 0.25MG 20X2ML
PULMICORT NEB 0.5MG 20X2ML
RHINOCORT TUBUHALER INH 100MCG 200DS
PULMICORT TURBUHALER INH 200MCG 200DS
SYMBICORT TURBUHALER INH 100MCG 120DS
SYMBICORT TURBUHALER INH 200MCG 60DS
BRILINTA TB 90MG UD 4X15
NIX CR RIN LICE 1% 59ML
KWELLADA-P 5% PERM LOT 100ML
ZYCLARA CR 3.75% PUMP 7.5G
ALDARA P CREAM 5% PUMP 7.5G
MIRENA IUS 1
YAZMIN TB 28
YASMIN TB 21
AERIUS ALRGY DESLO TB 5MG 100
XARELTO TB 10MG 50
XARELTO TB 15MG 90
XARELTO TB 20MG 90
KADIAN CAPS 10MG 100
KADIAN CAPS 100MG 50
KADIAN CAPS 20MG 100
KADIAN CAPS 50MG 100
SYNTHROID TB 0.1MG 1000
SYNTHROID TB 112MCG 90
SYNTHROID TB 0.125MG 1000
SYNTHROID TB 137MCG 90
SYNTHROID TB 0.15MG 1000
SYNTHROID TB 0.175MG 1000
SYNTHROID TB 200MCG 90
SYNTHROID TB 0.025MG 1000
SYNTHROID TB 0.05MG 1000
SYNTHROID TB 0.075MG 1000
SYNTHROID TB 88MCG 90
TECFIDERA CAPS 240MG 56
AVONEX PEN PRE-FIL 30MCG 1X4
ATROVENT INHALER HFA 200DS
JARDIANCE TB 10MG BLST 90
JARDIANCE TB 25MG BLST 30
TRAJENTA TB 5MG UD BLS 9X10
ELIQUIS TB 2.5MG 60
ELIQUIS TB 5MG BLS 6X10
SPRYCEL TB 80MG 30
ATASOL 15 COD TB 100
ATASOL 30 COD TB 100
GLUCAGON RDNA SYR 1MG 1X1ML
INS HUMALOG CARTRIDGE 5X3ML
INS HUMULIN R CART 5X3ML
DEPO TESTOST 100MG/ML 10ML
INS HUMULIN N CART 5X3ML
DIPHENHYDRAM INJ 50MG 25X1ML
METROCREAM CR 0.75% 60G
METROGEL TOP GEL 0.75% 60G
METROGEL TOP GEL 1% 55G
GENVOYA 150/150/200/10MG 30
STRIBILD 150/150/200/300MG30
ODEFSEY TB 200/25/25MG 30
COMPLERA TB 300MG 30
DESCOVY TB 200/10MG 30
DESCOVY TB 200/25MG 30
VOSEVI TB 400/100/100MG 28
FLOVENT HFA 125MCG/DS 120DS
FLOVENT HFA 250MCG/DS 120DS
ADVAIR MDI INH 125MCG 120DS
ADVAIR MDI INH 250MCG 120DS
NIX DERM CR 5% 30G
FLOVENT DISK PD 250MCG 60DS
ADVAIR DISKUS 50/250MCG INHALER 60DS
ADVAIR DISKUS 50/500MCG INHALER 60DS
FUZEON KIT VL 108MG 1
RITUXAN VL 10MG/ML 1X50ML
SPORANOX CAPS 100MG 30
REMICADE VL 10MG/ML 100MG
RISPERDAL CONSTA KIT 25MG
RISPERDAL CONSTA KIT 37.5MG
RISPERDAL CONSTA KIT 50MG
EPREX SYR 1000IU 6X0.5ML
EPREX SYR 2000IU 6X0.5ML
EPREX SYR 3000IU 6X0.3ML
EPREX SYR 4000IU 6X0.4ML
EPREX SYR 5000IU 6X0.5ML
EPREX SYR 6000IU 6X0.6ML
EPREX SYR 8000IU 6X0.8ML
EPREX SYR 10000IU 6X1ML
EPREX SYR 40000IU 1X1ML
SIMPONI SYR 50MG 0.5ML
SIMPONI A/INJECT 100MG 1ML
SIMPONI A/INJECT 50MG 0.5ML
INVEGA SUSTENNA SYR 150MGPFS
INVEGA SUSTENNA SYR 50MG PFS
INVEGA TRINZA SYRN 175MG 1
INVOKANA TB 100MG UD 30
INVOKANA TB 300MG UD 30
PREZISTA TB 150MG 240
PREZISTA TB 600MG 60
PREZISTA TB 800MG 30
CYCLEN DISCREET TB 28
TRI-CYCLEN DISCREET TB 28
INVEGA TB XR 3MG 30
INVEGA TB XR 6MG 30
DOVOBET GEL 50MCG/0.5MG 60G
DOVONEX OINT 50MCG/G 30G
DOVOBET OINTMENT 120G
PROTOPIC OINT 0.03% 30G
PROTOPIC OINT 0.10% 30G
FLUANXOL DEPOT100MG/ML 10X1ML
CLOPIXOL DEP 200MG/ML 10X1ML
TRINTELLIX TB 10MG 28
TRINTELLIX TB 20MG 28
TRINTELLIX TB 5MG 28
METHADOSE CHY ORAL SOL 1L
METHADOSE N/DYE S/F UNFLV 1L
ASMANEX TWISTHALER 200MCG 60
ASMANEX TWISTHALER 400MCG 60
NUVARING VAG RING 3
ISENTRESS TB 400MG 60
JANUMET TB 50MG/1000MG 60
JANUMET TB 50MG/500MG 60
JANUMET XR TB 50MG/1000MG 60
JANUVIA TB 100MG 100
JANUVIA TB 50MG 30
GILENYA CAPS 0.5MG 2X14
SEEBRI BREEZHALER 50MCG 3X10
LAMISIL CR 1% 30G
LAMISIL SP 1% 30ML
CIPRODEX OTIC SUSP 7.5ML
EXJADE TB 500MG BLST 28
INSUL NOVORAPID PEN 5X3ML
VICTOZA PRE FILLED 3X3.0ML
SAXENDA 6MG/ML PNPREFIL5X3ML
INSUL NOV GE NPH PEN 5X3ML
ABILIFY MAINTENA VL 300MG
ABILIFY MAINTENA VL 400MG
FRAGMIN SYRN 10000IU 5X0.4ML
FRAGMIN SYRN 12500IU 5X0.5ML
FRAGMIN SYRN 15000IU 5X0.6ML
FRAGMIN SYRN18000IU 5X0.72ML
FRAGMIN SYRN 5000IU 10X0.2ML
FRAGMIN SYRN 7500IU 5X0.3ML
FRAGMIN VL 25000IU/ML 3.8ML
DEXTROSE ANS 50% 25G/50ML 10X50ML
DEXTROSE SYR 50% LIFESHIELD 50ML
DEXTROSE SYR 50% 25G/50ML 10X50ML
INS HUMALOG KW 100U/ML 5X3ML
DEPO PROVERA 150MG/ML 1ML
ROBAXIN TB 500MG 50
IBAVYR TB 400MG 100
IBAVYR TB 600MG 100
BIPHENTIN CAPS 20MG 100
BIPHENTIN CAPS 30MG 100
BIPHENTIN CAPS 40MG 100
BIPHENTIN CAPS 50MG 50
BIPHENTIN CAPS 60MG 50
BIPHENTIN CAPS 80MG 50
BIPHENTIN CAPS 10MG 100
INSUL LANTUS CART 5X3.0ML
INSUL LANTUS SOLOSTAR 5X3ML
ALLEGRA 24 HOURS 120MG TB 18
ALLEGRA TB 60MG 36
VYVANSE CAPS 10MG 100
VYVANSE CAPS 20MG 100
VYVANSE CAPS 30MG 100
VYVANSE CAPS 40MG 100
VYVANSE CAPS 50MG 100
VYVANSE CAPS 60MG 100
MEZAVANT TB ER 1.2G 120
FLAMAZINE CR TUBE 50G
LATUDA FCT 120MG 30
LATUDA FCT 20MG 30
LATUDA FCT 40MG 30
LATUDA FCT 60MG 30
LATUDA FCT 80MG 30
DEXILANT CP DR 30MG 90
DEXILANT CP DR 60MG 90
COPAXONE SYR PREFIL20MG/ML30
COPAXONE SYR PREFIL40MG/ML12
ZYBAN TB 150MG 100
TRIUMEQ TB 600/50/300MG UD30
TIVICAY TB 50MG 30
Delivery Date: 13/05/2019
You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above.
An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process.
Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements.
The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page.
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.Contract duration
Refer to the description above for full details.
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Contact information
Contracting organization
- Organization
-
Public Works and Government Services Canada
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Summers(ph885), Julia
- Phone
- (819) 420-2951 ( )
- Email
- julia.summers@tpsgc-pwgsc.gc.ca
- Fax
- (819) 956-7340
- Address
-
Terrasses de la Chaudière 5th Floor
10 Wellington StreetGatineau, Quebec, K1A 0S5
Buying organization(s)
- Organization
-
Public Works and Government Services Canada
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada